Project Details
Description
This is an open-label, single-arm, Phase IIb study to evaluate the efficacy, safety, tolerability and PK profile of F901318 in participants with fungal infections lacking suitable alternative treatment options.
Status | Finished |
---|---|
Effective start/end date | 2/12/94 → 5/28/21 |
Funding
- Social Sciences and Humanities Research Council of Canada: US$16,994.00
ASJC Scopus Subject Areas
- Medicine(all)
- Philosophy
- Arts and Humanities(all)
- History